Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IBD

Can TNF inhibitors be administered during the third trimester?

As pregnancies frequently occur in patients with IBD, and given that TNF inhibitors are increasingly being used for treatment of this chronic intestinal disease, the discontinuation of biologic agents during the third trimester in patients with quiescent disease has been advocated owing to safety concerns.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cornish, J. et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56, 830–837 (2007).

    Article  CAS  Google Scholar 

  2. Zelinkova, Z. et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin. Gastroenterol. Hepatol. http://dx.doi.org/10.1016/j.cgh.2012.10.024.

  3. Dominitz, J. A., Young, J. C. & Boyko, E. J. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am. J. Gastroenterol. 97, 641–648 (2002).

    Article  Google Scholar 

  4. Reddy, D., Murphy, S. J., Kane, S. V., Present, D. H. & Kornbluth, A. A. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am. J. Gastroenterol. 103, 1203–1209 (2008).

    Article  CAS  Google Scholar 

  5. Singh, S., Sedgh, G. & Hussain, R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud. Fam. Plann. 41, 241–250 (2010).

    Article  Google Scholar 

  6. Habal, F. M. & Huang, V. W. Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Aliment. Pharmacol. Ther. 35, 501–515 (2012).

    Article  CAS  Google Scholar 

  7. Zelinkova, Z. et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment. Pharmacol. Ther. 33, 1053–1058 (2011).

    Article  CAS  Google Scholar 

  8. Mahadevan, U. et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am. J. Gastroenterol. 106, 214–223 (2011).

    Article  CAS  Google Scholar 

  9. Mahadevan, U. et al. PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy [abstract]. Gastroenterology 142 (Suppl. 5), S-149 (2012).

    Article  Google Scholar 

  10. Ben-Horin, S. et al. Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. J. Crohns Colitis 5, 555–558 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ole Haagen Nielsen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nielsen, O., Jess, T. Can TNF inhibitors be administered during the third trimester?. Nat Rev Gastroenterol Hepatol 10, 130–131 (2013). https://doi.org/10.1038/nrgastro.2012.248

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2012.248

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing